PPARγ and RhoBTB1 in hypertension.

Abstract:

PURPOSE OF REVIEW:This review provides an up-to-date understanding of how peroxisome proliferator activated receptor γ (PPARγ) exerts its cardioprotective effect in the vasculature through its activation of novel PPARγ target genes in endothelium and vascular smooth muscle. RECENT FINDINGS:In vascular endothelial cells, PPARγ plays a protective role by increasing nitric oxide bioavailability and preventing oxidative stress. RBP7 is a PPARγ target gene enriched in vascular endothelial cells, which is likely to form a positive feedback loop with PPARγ. In vascular smooth muscle cells, PPARγ antagonizes the renin-angiotensin system, maintains vascular integrity, suppresses vasoconstriction, and promotes vasodilation through distinct pathways. Rho-related BTB domain containing protein 1 (RhoBTB1) is a novel PPARγ gene target in vascular smooth muscle cells that mediates the protective effect of PPARγ by serving as a substrate adaptor between the Cullin-3 RING ubiquitin ligase and phosphodiesterase 5, thus restraining its activity through ubiquitination and proteasomal degradation. SUMMARY:In the vasculature, PPARγ exerts its cardioprotective effect through its transcriptional activity in endothelium and vascular smooth muscle. From the understanding of PPARγ's transcription targets in those pathways, novel hypertension therapy target(s) will emerge.

authors

Fang S,Sigmund CD

doi

10.1097/MNH.0000000000000579

subject

Has Abstract

pub_date

2020-03-01 00:00:00

pages

161-170

issue

2

eissn

1062-4821

issn

1473-6543

journal_volume

29

pub_type

杂志文章,评审
  • Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.

    abstract:PURPOSE OF REVIEW:Vascular endothelial growth factors (VEGFs) influence renal function through angiogenesis, with VEGF-A being the most potent inducer of vascular formation. In the normal glomerulus, tight homeostatic balance is maintained between the levels of VEGF-A isoforms produced by podocyte cells, and the VEGF r...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000256

    authors: Logue OC,McGowan JW,George EM,Bidwell GL 3rd

    更新日期:2016-09-01 00:00:00

  • Role of proteolysis in the activation of epithelial sodium channels.

    abstract:PURPOSE OF REVIEW:Epithelial sodium channels mediate Na+ transport across high resistance, Na+-transporting epithelia. This review describes recent findings that indicate that epithelial sodium channels are activated by the proteolytic release of inhibitory peptides from the alpha and gamma subunits. RECENT FINDINGS:N...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32821f6072

    authors: Hughey RP,Carattino MD,Kleyman TR

    更新日期:2007-09-01 00:00:00

  • Water channels.

    abstract::The aquaporin water channels are expressed in various fluid-transporting epithelia. Physiological and genetic investigations have revealed that aquaporin channel-like intrinsic protein is expressed in numerous tissues, but its significance in water transport physiology is unclear. It has been shown that aquaporin-coll...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199509000-00003

    authors: Fushimi K,Marumo F

    更新日期:1995-09-01 00:00:00

  • Iothalamate clearance and its use in large-scale clinical trials.

    abstract::Several recently completed or ongoing large-scale clinical trials, including the Modification of Diet in Renal Disease Study, the Diabetes Control and Complications Trial, and the African-American Study of Kidney Disease and Hypertension, have all chosen the renal clearance of sodium 125I-iothalmate to monitor renal d...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199511000-00010

    authors: Hall PM,Rolin H

    更新日期:1995-11-01 00:00:00

  • The role of incretins in salt-sensitive hypertension: the potential use of dipeptidyl peptidase-IV inhibitors.

    abstract:PURPOSE OF REVIEW:Incretin mimetics, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), as well as dipeptidyl peptidase-IV (DPP-IV) inhibitors, are used in the treatment of type 2 diabetes mellitus (T2DM). In addition to stimulating insulin secretion from pancreatic β cells,...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e328349af9d

    authors: Tanaka T,Nangaku M,Nishiyama A

    更新日期:2011-09-01 00:00:00

  • PHEX, FGF23, DMP1 and beyond.

    abstract:PURPOSE OF REVIEW:We aim to review the biological properties of novel molecules that are members of a kidney-bone axis involved in the regulation of phosphate homeostasis. In addition, we describe how an improved knowledge of the mechanisms leading to changes in renal phosphate handling may lead to the development of n...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e3282fd6e5b

    authors: Strom TM,Jüppner H

    更新日期:2008-07-01 00:00:00

  • Advances in the management of hyperkalemia in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Patients with chronic kidney disease (CKD) have an increased risk of hyperkalemia that increases both short-term and long-term mortality. Historically, managing hyperkalemia has relied upon dietary modifications, augmentation of urinary potassium excretion and enhanced enteral potassium elimination. T...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000320

    authors: Cowan AC,Gharib EG,Weir MA

    更新日期:2017-05-01 00:00:00

  • Hypertension in end-stage renal disease patients.

    abstract::The prevalence of hypertension is extremely high in end-stage renal disease, and is a probable contributor to the epidemic of cardiovascular disease in end-stage renal disease. However, the paucity of prospective, randomized clinical trials makes it difficult to precisely define treatment strategies. Therefore, at pre...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200005000-00012

    authors: Zager P,Nikolic J,Raj DS,Tzamaloukas A,Campbell M

    更新日期:2000-05-01 00:00:00

  • Cognitive and physical function in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Both cognitive and physical function are commonly impaired in individuals with chronic kidney disease (CKD), resulting in important impacts on their quality of life and overall health. This review summarizes the burden of cognitive and physical impairment in CKD, focusing on recent research that highl...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/01.mnh.0000444821.87873.7b

    authors: Weiner DE,Seliger SL

    更新日期:2014-05-01 00:00:00

  • Regulation of sodium transport by ENaC in the kidney.

    abstract:PURPOSE OF REVIEW:The amiloride-sensitive epithelial sodium channel (ENaC) plays a major role in the regulation of sodium transport in the collecting duct and hence sodium balance. This review describes recent findings in the regulation of ENaC function by serine proteases in particular and other regulatory aspects. R...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e328332bda4

    authors: Hamm LL,Feng Z,Hering-Smith KS

    更新日期:2010-01-01 00:00:00

  • Safety of intravenous iron use in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Iron deficiency anaemia (IDA) is common and associated with fatigue, reduced quality of life and poorer clinical outcomes. Treatment with oral iron is often inadequate and international guidelines recommend intravenous (i.v.) iron as the preferred option for the treatment of IDA in certain clinical si...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000263

    authors: Kalra PA,Bhandari S

    更新日期:2016-11-01 00:00:00

  • Triumph and tragedy: anemia management in chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Recent trial data have resulted in a reevaluation of the management of anemia in chronic kidney disease, including the use of erythropoiesis-stimulating agents, intravenous iron, and novel pharmaceuticals. In this review, we evaluate the latest research on anemia management in chronic kidney disease. ...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32830c488d

    authors: Novak JE,Szczech LA

    更新日期:2008-11-01 00:00:00

  • Calciphylaxis.

    abstract:PURPOSE OF REVIEW:Calciphylaxis remains a poorly understood vascular calcification disorder with predilection for patients with end-stage renal disease (ESRD). Recent data from large patient registries and databases have begun to provide information regarding incidence, risk factors, and outcomes in patients with calci...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000328

    authors: Nigwekar SU

    更新日期:2017-07-01 00:00:00

  • Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?

    abstract:PURPOSE OF REVIEW:Non-valvular atrial fibrillation is common in patients with severe chronic kidney disease (CKD) and historically patients have been treated with vitamin K antagonists (VKA). However, these agents have questionable efficacy and are associated with increased bleeding risk. Non-vitamin K oral anticoagula...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000443

    authors: Kalra PA,Burlacu A,Ferro CJ,Covic A

    更新日期:2018-11-01 00:00:00

  • Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease.

    abstract:PURPOSE OF REVIEW:Chronic kidney disease (CKD) remains a serious diabetic complication despite the use of widely employed interventions such as angiotensin-converting enzyme inhibitors and glucose-lowering treatments. Accumulation of methylglyoxal, a highly reactive glucose metabolite and a major precursor in the forma...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000465

    authors: Hanssen NMJ,Stehouwer CDA,Schalkwijk CG

    更新日期:2019-01-01 00:00:00

  • Intrarenal renin-angiotensin system in regulation of glomerular function.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to provide an update on the current knowledge regarding the role of the intrarenal rennin-angiotensin system (RAS) in the regulation of glomerular function including glomerular dynamics and filtration rate, glomerular permeability and structural alterations during chronic...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/01.mnh.0000436544.86508.f1

    authors: Navar LG

    更新日期:2014-01-01 00:00:00

  • Renal phosphate transporters.

    abstract:PURPOSE OF REVIEW:Phosphate homeostasis is tightly controlled by the coordinated activity of bone, kidney, intestine, and parathyroid gland. The renal phosphate transporters have emerged as key regulators of both total body phosphate homeostasis and serum phosphate concentration. This review focuses on the latest updat...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000053

    authors: Lederer E

    更新日期:2014-09-01 00:00:00

  • Molecular and cellular determinants of mineralocorticoid selectivity.

    abstract::Aldosterone plays a major role in the regulation of renal sodium reabsorption, of extracellular fluid volume and blood pressure. Such specific mineralocorticoid physiological adaptations occur despite the large prevalence of glucocorticoid hormones over aldosterone in the plasma. Indeed both classes of hormones bind w...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199901000-00008

    authors: Farman N

    更新日期:1999-01-01 00:00:00

  • Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues.

    abstract:PURPOSE OF REVIEW:The discovery of the extracellular calcium-sensing receptor, CasR has broadened our understanding of calcium homeostasis and led to the development of new pharmacological agents, calcimimetics, for treating hyperparathyroidism. In the present review, I discuss the function of CasR as well as provide e...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200307000-00002

    authors: Quarles LD

    更新日期:2003-07-01 00:00:00

  • The assessment of baroreflex sensitivity in patients with chronic kidney disease: implications for vasomotor instability.

    abstract:PURPOSE OF REVIEW:Autonomic dysfunction is well recognized in chronic kidney disease. The baroreflex arc is an important component of the autonomic nervous system and influences vasodilatation and heart rate in response to information derived from baroreceptors located in the aorta and common carotid arteries. Appropri...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/01.mnh.0000185981.02578.0e

    authors: Chesterton LJ,McIntyre CW

    更新日期:2005-11-01 00:00:00

  • The epidemiology of hypertension-related renal disease.

    abstract::An increasing number of population-based studies and clinical trials have examined the role of blood pressure in renal disease. Recent reports indicate that elevations of blood pressure, even within the normotensive range, may result in renal damage. The available evidence suggests that blood pressure reduction dimini...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199305000-00007

    authors: Perneger TV,Whelton PK

    更新日期:1993-05-01 00:00:00

  • Dietary salt and hypertension.

    abstract::Sodium restriction is the most commonly used lifestyle modification for control of hypertension. Nevertheless, there is no consensus on the relative importance of salt in the development of hypertension, nor is the physiological mechanism(s) responsible for salt-induced elevations of blood pressure clearly understood....

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199603000-00012

    authors: Hatton DC,McCarron DA

    更新日期:1996-03-01 00:00:00

  • Molecular physiology of the thiazide-sensitive sodium-chloride cotransporter.

    abstract:PURPOSE OF REVIEW:This review summarizes recent advances in the understanding of the molecular physiology and regulation of the thiazide-sensitive sodium-chloride cotransporter (NCC). RECENT FINDINGS:Mutations of with-no-lysine (WNK) kinases 1 and 4 result in hyperactivity of NCC and familial hyperkalemic hypertension...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0b013e32832f2fcb

    authors: Ko B,Hoover RS

    更新日期:2009-09-01 00:00:00

  • Tubulointerstitial disease: role of ischemia and microvascular disease.

    abstract:PURPOSE OF REVIEW:Tubulointerstitial injury is characteristic of aging-associated renal injury and progressive renal disease. Salt-sensitive hypertension is also associated with tubulointerstitial inflammation, especially when accompanied by microvascular disease. Here we summarize recent studies on the pathogenesis an...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-200305000-00003

    authors: Nakagawa T,Kang DH,Ohashi R,Suga S,Herrera-Acosta J,Rodriguez-Iturbe B,Johnson RJ

    更新日期:2003-05-01 00:00:00

  • Therapeutic microRNAs in polycystic kidney disease.

    abstract:PURPOSE OF REVIEW:microRNAs (miRNAs) are short noncoding RNAs that function as sequence-specific inhibitors of gene expression. Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause of end-stage kidney failure with limited treatment options. The realization that miRNA upregulation, and...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000333

    authors: Yheskel M,Patel V

    更新日期:2017-07-01 00:00:00

  • Role of mesenchymal stem cells in kidney injury and fibrosis.

    abstract:PURPOSE OF REVIEW:Multiple studies have established the beneficial role of mesenchymal stem cell (MSC) therapy for kidney injury. In this review we will discuss the recent identification of Gli1 as a marker for perivascular MSC and the role of this cell population in kidney fibrosis. RECENT FINDINGS:Recent studies dem...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000230

    authors: Kuppe C,Kramann R

    更新日期:2016-07-01 00:00:00

  • Waiting times in renal transplant candidates with a history of malignancy: time for a change?

    abstract:PURPOSE OF REVIEW:With the aging population of kidney transplant candidates, a history of malignancy is an increasingly prevalent finding. Tumors can constitute a contraindication for transplantation or can lead to a delay of acceptance to the waiting-list. Current waiting time guidelines mainly refer to early data col...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章

    doi:10.1097/MNH.0000000000000652

    authors: Bojic M,Watschinger C,Reiter T,Watschinger B

    更新日期:2020-11-01 00:00:00

  • Recent advances in the mechanism of action of cyclosporine and FK506.

    abstract::The immunosuppressants cyclosporine and FK506 (tacrolimus) are extremely potent inhibitors of T-lymphocyte activation. Recent studies have shown that these agents are actually prodrugs that become active only when bound to specific members of the cyclophilin or FK506 binding protein receptor gene families. The cyclosp...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199212000-00008

    authors: Tocci MJ,Sigal NH

    更新日期:1992-12-01 00:00:00

  • Angiotensin-(1-7) as a strategy in the treatment of hypertension?

    abstract:PURPOSE OF REVIEW:The renin-angiotensin system plays an important role in cardiovascular disease via the production of angiotensin II. Over the past decades, however, more and more evidence has accumulated suggesting an important role for another angiotensin: Angiotensin-(1-7) [Ang-(1-7)]. In this review, we discuss th...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/MNH.0000000000000050

    authors: van Twist DJ,Kroon AA,de Leeuw PW

    更新日期:2014-09-01 00:00:00

  • Roles of growth hormone and growth factors in the pathogenesis and treatment of kidney disease.

    abstract::Growth hormone and a number of polypeptide growth factors exert actions on renal development, growth, and metabolism and on repair processes following renal injury. There is increasing evidence that under selected circumstances, these agents play roles in the pathogenesis of kidney disease and that under others, they ...

    journal_title:Current opinion in nephrology and hypertension

    pub_type: 杂志文章,评审

    doi:10.1097/00041552-199301000-00010

    authors: O'Shea M,Miller SB,Finkel K,Hammerman MR

    更新日期:1993-01-01 00:00:00